81% OF PARTICIPANTS AVOIDED BACK SURGERY TWO YEARS LATER WITHOUT COMPLICATIONS

The Article Accepted and Published by The US National Library of Medicine, featured in International Orthopaedics on July 10, 2015; “Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up.” Show there were no complications from the percutaneous bone marrow aspiration or disc injection. Of 26 patients, 24 (92 %) avoided surgery through 12 months, while 21 (81 %) avoided surgery through two years.

Total and rate of pain reduction were linked to mesenchymal stem cell concentration through 12 months. Only five of the 26 patients elected to undergo surgical intervention (fusion or artificial disc replacement) by the two year milestone. in conclusion, this study provides evidence of safety and feasibility in the non-surgical treatment of discogenic pain with autologous BMC, with durable pain relief (71 % VAS reduction) and ODI improvements (> 64 %) through two years.

Read the Complete Article Here